CompaniesByCap
TXG
10x Genomics Inc. (TXG)
NASDAQ · Healthcare

10x Genomics Inc. Income Statement 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenues
Revenue642.8M610.8M618.7M516.4M490.5M298.8M245.9M146.3M71.1M
Gross Profit443.9M414.5M409.3M396.0M416.4M240.4M184.9M117.7M60.5M
Profitability
Operating Income-61.0M-194.6M-265.3M-167.9M-52.3M-534.1M-30.6M-110.8M-18.4M
EBITDA
Net Income-43.5M-182.6M-255.1M-166.0M-58.2M-542.7M-31.3M-112.5M-18.8M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)125M120M117M114M110M101M39M15M

10x Genomics Inc. Income Statement — FAQ

10x Genomics Inc. (TXG) income statement over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TXG's income statement history?

The chart and table above show 10x Genomics Inc.'s income statement by year and by quarter, including the growth rate.